Goodwill and Intangible Assets (Tables)

12 Months Ended

Dec. 31, 2021

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Finite-lived and Indefinite-lived Intangible Assets

The following table represents our finite-lived and indefinite-lived intangible assets as of December 31, 2021 and 2020 (in thousands):

	2021		2020
Finite-lived intangible assets:
Customer relationships	$	192,800	$	202,546
Developed technology	219,706		227,247
Trade names	25,154		26,261
Other intangible assets	616		1,035
Total gross finite-lived intangible assets	438,276		457,089
Accumulated amortization - Customer relationships	65,106		56,787
Accumulated amortization - Developed technology	68,488		56,933
Accumulated amortization - Trade names	16,500		16,837
Accumulated amortization - Other intangible assets	506		902
Total accumulated amortization	150,600		131,459
Net finite-lived intangible assets	$	287,676	$	325,630
Indefinite-lived intangible assets:
IPR&D	$	112,006	$	112,006
Goodwill	899,525		922,318
Total indefinite-lived intangible assets	$	1,011,531	$	1,034,324

Schedule of Amortization Periods for Finite-lived Intangible Assets

The amortization periods for our finite-lived intangible assets as of December 31, 2021, are as follows: 

	Minimum Life in years	Maximum Life in years
Customer relationships	8	18
Developed technology	14	17
Trade names	15	15

Schedule of Finite-lived Intangible Assets Estimated Future Amortization Expense

The estimated future amortization expense based on our finite-lived intangible assets at December 31, 2021, is as follows (in thousands):

2022	$	25,980
2023	25,980
2024	25,980
2025	25,980
2026	25,980
Thereafter	157,776
Total	$	287,676

Schedule of Goodwill Carrying Amounts

The following table represents the changes in the carrying amount of goodwill by reportable segment (in thousands):

	Cardiopulmonary		Neuromodulation		Advanced Circulatory Support		Other (1)		Total
December 31, 2019	$	394,735	$	398,754	$	102,526	$	19,779	$	915,794
Impairment (2)	—		—		—		(21,269)		(21,269)
Foreign currency adjustments	26,303		—		—		1,490		27,793
December 31, 2020	421,038		398,754		102,526		—		922,318
Foreign currency adjustments	(22,793)		—		—		—		(22,793)
December 31, 2021	$	398,245	$	398,754	$	102,526	$	—	$	899,525

(1)Other includes goodwill associated the Company’s Heart Valves business, which was disposed of on June 1, 2021.

(2)During the year ended December 31, 2020, the Company recognized a $21.3 million impairment of goodwill allocated to Heart Valves. Refer to “Note 4. Divestiture of Heart Valve Business” for additional information.